Karen Knudsen: Clinical trials are the most advanced form of cancer care
Karen Knudsen, Executive Strategic Advisor and Immediate Past CEO of ACS, shared a post on LinkedIn:
“Clinical trials are the most advanced form of cancer care. Period.
Truly delighted to participate on the panel today during JPM25 to discuss solutions for expanding access to clinical trials.
As a former National Cancer Institute (NCI) cancer center director and President of AACI (Association of American Cancer Institutes), I can state with certainty that every major cancer center strives daily to expand access to this vital form of care.
We need to think differently in order to ensure that more patients are evaluated for and offered clinical trials!
Thank you for organizing, Paradigm Health and CEO Roundtable on Cancer, and I look forward to seeing you there.”
Karen Knudsen is the Executive Strategic Advisor and Immediate Past CEO of the American Cancer Society (ACS). Prior to joining ACS, Dr. Knudsen served as executive vice president of Oncology Services and enterprise director for Sidney Kimmel Cancer Center at Jefferson Health.
She also served as president for the Association of American Cancer Institutes (AACI) and on the board of directors of the American Association for Cancer Research (AACR). She serves on the board of advisors for the National Cancer Institute, on 12 external advisory boards for NCI-designated cancer centers and on Exai Bio.
She is an active member of several committees with the American Society for Clinical Oncology (ASCO), in addition to serving on other academic and for-profit advisory boards.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023